Professor Matthew Todd (UCL School of Pharmacy), one of the founders of the open-source pharmaceuticals initiative, says the pandemic has driven global collaboration on developing vaccines and antiviral treatments, which could have a lasting impact on the industry.
Read: FT (£)
Close
